[1]
2017. Estimation of Serum Interleukin-6 level as a Useful Marker for Clinical Severity of Sickle Cell Disease among Sudanese Patients. International Journal of Multidisciplinary and Current Research. 5, 3 (May 2017), 642–644. DOI:https://doi.org/10.14741/ijmcr/v.5.3.20.